SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Stuttgart
Börse Börse Stuttgart
ISIN US717081DK61
EUR
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US717081DK61
Symbol PFE
Währung EUR
Börse Börse Stuttgart Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Pfizer läuft ähnlich wie der DAX (2.91 %) vom 05.06.2014 bis 02.11.2017

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

1.560 News & Informationen zur Pfizer Aktie

  • Video
    Investflow

  • Video
    Investflow

  • Video
    Investflow

  • Video
    Investflow

  • FDA committee to discuss COVID-19 booster shots
    marketwatch.com

    FDA committee to discuss COVID-19 booster shots

    An influential Food and Drug Administration advisory committee plans to meet Sept. 17 to discuss extra doses of the COVID-19 vaccines, including the…

  • Moderna Asks FDA to Approve Covid Booster Shot
    thestreet.com

    Moderna Asks FDA to Approve Covid Booster Shot

    Moderna shares rose Thursday after the company asked the FDA to approve use of a third, or booster, shot of its Covid-19 vaccine.

  • 5 Top-Ranked ETFs That Outperformed in August
    entrepreneur.com

    5 Top-Ranked ETFs That Outperformed in August

    Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.

  • Moderna says covid-19 vaccine contaminant in Japan was stainless steel, sees no safety issue
    livemint.com

    Moderna says covid-19 vaccine contaminant in Japan was stainless steel, sees no safety issue

    Japan last week recalled three lots of the Moderna vaccine containing a total of 1.63 million doses

  • Write a Prescription for Equal-Weight Healthcare ETF
    etftrends.com

    Write a Prescription for Equal-Weight Healthcare ETF

    Many sector exchange traded funds that weight components by market capitalization are heavily concentrated in just a few stocks.

  • Wells Fargo Pushes Back Its Return to Office by Two More Weeks
    wealthmanagement.com

    Wells Fargo Pushes Back Its Return to Office by Two More Weeks

    Wells Fargo will now begin bringing back staffers who have been working remotely starting Oct. 18, rather than Oct. 4.

  • FDA resignations over White House booster shot guidance a 'mess for administration'
    news.google.com

    FDA resignations over White House booster shot guidance a 'mess for administration'

    Reports that Food and Drug Administration officials plan to step down over the White House’s COVID-19 booster shot guidance have created a “mess” for the Biden administration, according to Dr. Mark Siegel.

  • Europe's CDC Breaks With Biden Admin, Says No Urgent Need For COVID Boosters
    zerohedge.com

    Europe's CDC Breaks With Biden Admin, Says No Urgent Need For COVID Boosters

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • Strong Vaccine Demand Boosting Pharma Sales
    etfdb.com

    Strong Vaccine Demand Boosting Pharma Sales

    There are multiple coronavirus vaccines on the market, and with the likelihood of booster shots increasing by the day, the revenue outlook for healthcare

  • Strong Vaccine Demand Lifting Pharma Sales
    etftrends.com

    Strong Vaccine Demand Lifting Pharma Sales

    There are multiple coronavirus vaccines on the market, and with the likelihood of booster shots increasing by the day, the revenue outlook…

  • FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug Labels
    zacks.com

    FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug Labels

    The FDA requires a heart-risk warning on the label of JAK inhibitor medicines, Pfizer's (PFE) Xeljanz/Xeljanz XR, Lilly (LLY)/Incyte's (INCY) Olumiant, and AbbVie's (ABBV) Rinvoq.

  • Thursday Morning Reads
    optionmillionaires.com

  • Cathie Wood’s ARK Invest Buys Over 380,000 Shares of Pfizer – 24
    247wallst.com

    Cathie Wood’s ARK Invest Buys Over 380,000 Shares of Pfizer – 24

    One of Cathie Wood's ARK Invest exchange-traded funds bought over 380,000 shares of Pfizer on September 1.

  • Pfizer, Merck test oral COVID-19 therapeutics; Oral vaccine on the way? (NYSE:PFE)
    seekingalpha.com

    Pfizer, Merck test oral COVID-19 therapeutics; Oral vaccine on the way? (NYSE:PFE)

    Oral drugs that combat COVID-19 are garnering interest from drugmakers and countries alike, as the coronavirus battle moves beyond jabs and syringes

  • China limits children to 3 hours of online gaming a week
    businessmirror.com.ph

    China limits children to 3 hours of online gaming a week

    The gaming restrictions are part of an ongoing crackdown on technology companies, amid concerns that technology firms — many of which provide ubiquitous messaging, payments and gaming services — may have an outsized influence on society.

  • US FDA seeks new warnings on arthritis drugs from Pfizer, Lilly and AbbVie
    foxbusiness.com

  • Cathie Wood’s ARK Invest Buys for 9
    247wallst.com

  • Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan
    financialpost.com

    Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan

    TAOYUAN — The first batch of BioNTech SE’s COVID-19 vaccine arrived in Taiwan on Thursday, helped by the involvement of two of the world’s most important tech…

  • Helped by tech giants, BioNTech vaccines finally reach Taiwan
    financialpost.com

    Helped by tech giants, BioNTech vaccines finally reach Taiwan

    TAOYUAN — The first batch of BioNTech SE’s COVID-19 vaccine arrived in Taiwan on Thursday, after months of heated political and diplomatic wrangling and helped…

  • Moderna seeks U.S. authorization for COVID-19 vaccine booster
    financialpost.com

    Moderna seeks U.S. authorization for COVID-19 vaccine booster

    Moderna Inc on Wednesday asked the U.S. Food and Drug Administration (FDA) to allow the use of a third booster dose of its COVID-19 vaccine.

  • Moderna seeks U.S. authorization for COVID-19 vaccine booster By Reuters
    investing.com

    Moderna seeks U.S. authorization for COVID-19 vaccine booster By Reuters

    Moderna seeks U.S. authorization for COVID-19 vaccine booster

  • Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
    zacks.com

    Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

    Pfizer (PFE) closed at $46.04 in the latest trading session, marking a -0.07% move from the prior day.

  • Moderna Stock Forecast 2025: 70% Gain in Five Years
    moneymorning.com

    Moderna Stock Forecast 2025: 70% Gain in Five Years

    The Moderna stock forecast from Wall Street would have you think this stock is overbought. But there is more to Moderna stock than COVID vaccines…

  • Moderna asks FDA to evaluate COVID-19 vaccine booster candidate
    marketwatch.com

    Moderna asks FDA to evaluate COVID-19 vaccine booster candidate

    Moderna Inc. undefined said late Wednesday it is submitting documents to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of…

  • EU health body says no urgent need for vaccine boosters
    financialpost.com

    EU health body says no urgent need for vaccine boosters

    The European Centre for Disease Prevention and Control (ECDC) said on Wednesday there was no urgent need for booster doses of COVID-19 vaccines for the fully…

  • Moderna : U.S. administers third dose of COVID-19 vaccine to over 1 million people - CDC
    marketscreener.com

    Moderna : U.S. administers third dose of COVID-19 vaccine to over 1 million people – CDC

    The United States has administered a
    third dose of either Pfizer Inc or Moderna Inc's
    COVID-19 vaccines to over 1 million people as of
    Wednesday morning, the U.S. Centers for Disease Control… | September 1, 2021

  • Pfizer, Merck launch new trials of oral COVID-19 drugs
    financialpost.com

    Pfizer, Merck launch new trials of oral COVID-19 drugs

    Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as the race to develop an…

  • 15 Good Stocks to Buy Right Now
    insidermonkey.com

    15 Good Stocks to Buy Right Now

    Investors are practicing extreme caution amid uncertainty caused by the resurgence of COVID-19 all over the world.

  • 5 Sector ETFs That Beat the Market in August
    entrepreneur.com

    5 Sector ETFs That Beat the Market in August

    Most of the rally was powered by a huge vaccination drive, upbeat corporate earnings and the Fed's dovish comments that have renewed optimism for sust…

  • Pfizer Stock: Vaccine Outperformance Propels For The Long Run (NYSE:PFE)
    seekingalpha.com

    Pfizer Stock: Vaccine Outperformance Propels For The Long Run (NYSE:PFE)

    Pfizer's vaccine has and will continue to catapult revenues and net income, with looming boosters extending demand into the future. Read about PFE stock here.

  • Majority of U.S. companies may mandate COVID-19 vaccine in coming months
    investing.com

    Majority of U.S. companies may mandate COVID-19 vaccine in coming months

    Majority of U.S. companies may mandate COVID-19 vaccine in coming months – survey

  • Global Industry Analysts Predicts The World Human Reproductive Technologies Market To Reach $28 Billion By 2026
    thestreet.com

    Global Industry Analysts Predicts The World Human Reproductive Technologies Market To Reach $28 Billion By 2026

    SAN FRANCISCO, Sept. 1, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Pfizer starts dosing in pivotal trial for oral COVID-19 drug (NYSE:PFE)
    seekingalpha.com

    Pfizer starts dosing in pivotal trial for oral COVID-19 drug (NYSE:PFE)

    Pfizer (PFE) announced that the first patient was dosed in a pivotal Phase 2/3 clinical trial designed to evaluate PF-07321332, the company’s investigational oral therapy targeted…

  • The debate over COVID-19 booster shots picks up steam. Will they be limited to certain high-risk Americans?
    marketwatch.com

    The debate over COVID-19 booster shots picks up steam. Will they be limited to certain high-risk Americans?

    One Wall Street analyst thinks that COVID-19 booster shots will only be available to people at higher risk of cases of COVID-19, and not all vaccinated…

  • Pfizer starts dosing patients in oral COVID-19 drug trial By Reuters
    investing.com

    Pfizer starts dosing patients in oral COVID-19 drug trial By Reuters

    Pfizer starts dosing patients in oral COVID-19 drug trial

  • Pfizer starts dosing patients in oral COVID-19 drug trial
    financialpost.com

    Pfizer starts dosing patients in oral COVID-19 drug trial

    Pfizer Inc said on Wednesday it had started dosing in a mid-to-late-stage trial of its oral antiviral therapy for COVID-19 in non-hospitalized, symptomatic…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Die Pfizer Aktie konnte seit dem 05.06.2014 eine Rendite von 38% erwirtschaften.

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic